Skip to main content
Multiple Myeloma, NCCN News
Selecting Treatment for Relapsed/Refractory Multiple Myeloma in the Era of Multiple Choices
Meg Barbor, MPH
Meg Barbor, MPH
Read More
NCCN News, Biosimilars
Biosimilars Are Key Components of Oncology Today: Brush Up on the Basics
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Leukemia, NCCN News
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukemia?
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Ovarian Cancer
The Experiences of Women with Ovarian Cancer: From the First Symptoms Through Repeated Courses of Chemotherapy
Read More
Ovarian Cancer
PARP Inhibitor Therapy Improves Outcomes for Ovarian Cancer Patients Who Have BRCA Wild-Type Tumors
Read More
Ovarian Cancer
Oral Medications Pose Challenges for Cancer Treatment But There Are Strategies for Improving Patient Adherence
Read More
Ovarian Cancer
Changes to Medicare Part D in 2020 and What They Mean for Patients with Cancer
Read More
Sarcoma, FDA Updates
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
Clinical Trials
Delivering High-Value Personalized Interventions
Chase Doyle
Read More
Bladder Cancer, Immunotherapy, FDA Updates
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Read More
Page 144 of 197
Results 1431 - 1440 of 1963